Literature DB >> 19104908

Adult T-cell leukemia after immunosuppressive therapy for systemic lupus erythematosus.

Yoshiko Shimamoto1, Shosaku Nomura2, Kazuyoshi Ishii3, Michiomi Shimizu3, Yoshio Ozaki1, Tomoki Ito1, Fumiaki Urase4, Yasuhiro Maeda4, Shirou Fukuhara1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19104908     DOI： 10.1007/s12185-008-0239-4

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  8 in total

1.  Human T-cell leukemia virus type I associated lymphadenitis.

Authors:  K Ohshima; M Kikuchi; Y Masuda; Y Sumiyoshi; F Eguchi; H Mohtai; M Takeshita; N Kimura
Journal:  Cancer       Date:  1992-01-01       Impact factor: 6.860

Review 2.  Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses.

Authors:  Miranda K Adelman; John J Marchalonis
Journal:  Clin Immunol       Date:  2002-02       Impact factor: 3.969

3.  Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.

Authors:  Peter Gergely; Rudolf Pullmann; Christina Stancato; Laszlo Otvos; Agnes Koncz; Antal Blazsek; Gyula Poor; Kevin E Brown; Paul E Phillips; Andras Perl
Journal:  Clin Immunol       Date:  2005-08       Impact factor: 3.969

4.  Interaction of MHC class I molecules with the transporter associated with antigen processing.

Authors:  W K Suh; M F Cohen-Doyle; K Fruh; K Wang; P A Peterson; D B Williams
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

5.  Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus.

Authors:  K Lipka; B Tebbe; U Finckh; A Rolfs
Journal:  Clin Exp Dermatol       Date:  1996-01       Impact factor: 3.470

6.  C-type virus expression in systemic lupus erythematosus.

Authors:  S Panem; N G Ordóñez; W H Kirstein; A I Katz; B H Spargo
Journal:  N Engl J Med       Date:  1976-08-26       Impact factor: 91.245

7.  Four regulatory elements in the human c-fos promoter mediate transactivation by HTLV-1 Tax protein.

Authors:  C Alexandre; B Verrier
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

8.  Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus.

Authors:  Masaki Akimoto; Kakushi Matsushita; Yukio Suruga; Noriko Aoki; Atsuo Ozaki; Kimiharu Uozumi; Chuwa Tei; Naomichi Arima
Journal:  J Rheumatol       Date:  2007-08-01       Impact factor: 4.666
  8 in total
  2 in total

1.  Lupus nephritis class I accompanied by tubulointerstitial nephritis with marked T-lymphocyte infiltration in an HTLV-1 positive patient.

Authors:  Toshiyuki Imasawa; Hiroshi Kitamura; Motonobu Nishimura; Takehiko Kawaguchi; Katsuyoshi Takata; Tadashi Yoshino; Yuichi Sugisaki
Journal:  CEN Case Rep       Date:  2012-11-03

Review 2.  Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL).

Authors:  Sanaz Ahmadi Ghezeldasht; Abbas Shirdel; Mohammad Ali Assarehzadegan; Tahereh Hassannia; Hosian Rahimi; Rahele Miri; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.